Objective Ovarian cancers comprise several histologically distinct tumour groups with widely different prognosis. We aimed to describe the worldwide distribution of ovarian cancer histology and to understand what role this may play in international variation in survival. Methods The CONCORD programme is the largest population-based study of global trends in cancer survival. Data on 681,759 women diagnosed during 1995–2009 with cancer of the ovary, fallopian tube, peritoneum and retroperitonum in 51 countries were included. We categorised ovarian tumours into six histological groups, and explored the worldwide distribution of histology. Results During 2005–2009, type II epithelial tumours were the most common. The proportion was much higher in Oceania (73.1%), North America (73.0%) and Europe (72.6%) than in Central and South America (65.7%) and Asia (56.1%). By contrast, type I epithelial tumours were more common in Asia (32.5%), compared with only 19.4% in North America. From 1995 to 2009, the proportion of type II epithelial tumours increased from 68.6% to 71.1%, while the proportion of type I epithelial tumours fell from 23.8% to 21.2%. The proportions of germ cell tumours, sex cord-stromal tumours, other specific non-epithelial tumours and tumours of non-specific morphology all remained stable over time. Conclusions The distribution of ovarian cancer histology varies widely worldwide. Type I epithelial, germ cell and sex cord-stromal tumours are generally associated with higher survival than type II tumours, so the proportion of these tumours may influence survival estimates for all ovarian cancers combined. The distribution of histological groups should be considered when comparing survival between countries and regions.

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) / Matz, M.; Coleman, M. P.; Sant, M.; Chirlaque, M. D.; Visser, O.; Gore, M.; Allemani, C.; Bouzbid, S.; Hamdi-Cherif, M.; Zaidi, Z.; Bah, E.; Swaminathan, R.; Nortje, S. H.; C. Stefan, D.; El Mistiri, M. M.; Bayo, S.; Malle, B.; Manraj, S. S.; Sewpaul-Sungkur, R.; Fabowale, A.; Ogunbiyi, O. J.; Bradshaw, D.; Somdyala, N. I. M.; Abdel-Rahman, M.; Jaidane, L.; Mokni, M.; Kumcher, I.; Moreno, F.; Gonzalez, M. S.; Laura, E. A.; Espinola, S. B.; Calabrano, G. H.; Carballo Mazzoleni, G.; Giacomin, A.; Bella, F.; Castaing, M.; Sutera, A.; Gola, G.; Ferretti, S.; Serraino, D.; Zucchetto, A.; Lillini, R.; Vercelli, M.; Busco, S.; Pannozzo, F.; Vitarelli, S.; Ricci, P.; Pascucci, C.; Autelitano, M.; Cirilli, C.; Federico, M.; Fusco, M.; Vitale, M. F.; Usala, M.; Cusimano, R.; Mazzucco, W.; Michiara, M.; Sgargi, P.; Maule, M. M.; Sacerdote, C.; Tumino, R.; Di Felice, E.; Vicentini, M.; Falcini, F.; Cremone, L.; Budroni, M.; Cesaraccio, R.; Contrino, M. L.; Tisano, F.; Fanetti, A. C.; Maspero, S.; Candela, G.; Scuderi, T.; Gentilini, M. A.; Piffer, S.; Rosso, S.; Sacchetto, L.; Caldarella, A.; La Rosa, F.; Stracci, F.; Contiero, P.; Tagliabue, G.; Dei Tos, A. P.; Zorzi, M.; Zanetti, R.; Baili, P.; Berrino, F.; Gatta, G.; Capocaccia, R.; De Angelis, R.; Liepina, E.. - In: GYNECOLOGIC ONCOLOGY. - ISSN 0090-8258. - 144:2(2017), pp. 405-413. [10.1016/j.ygyno.2016.10.019]

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

Federico M.;Budroni M.;Scuderi T.;Rosso S.;
2017

Abstract

Objective Ovarian cancers comprise several histologically distinct tumour groups with widely different prognosis. We aimed to describe the worldwide distribution of ovarian cancer histology and to understand what role this may play in international variation in survival. Methods The CONCORD programme is the largest population-based study of global trends in cancer survival. Data on 681,759 women diagnosed during 1995–2009 with cancer of the ovary, fallopian tube, peritoneum and retroperitonum in 51 countries were included. We categorised ovarian tumours into six histological groups, and explored the worldwide distribution of histology. Results During 2005–2009, type II epithelial tumours were the most common. The proportion was much higher in Oceania (73.1%), North America (73.0%) and Europe (72.6%) than in Central and South America (65.7%) and Asia (56.1%). By contrast, type I epithelial tumours were more common in Asia (32.5%), compared with only 19.4% in North America. From 1995 to 2009, the proportion of type II epithelial tumours increased from 68.6% to 71.1%, while the proportion of type I epithelial tumours fell from 23.8% to 21.2%. The proportions of germ cell tumours, sex cord-stromal tumours, other specific non-epithelial tumours and tumours of non-specific morphology all remained stable over time. Conclusions The distribution of ovarian cancer histology varies widely worldwide. Type I epithelial, germ cell and sex cord-stromal tumours are generally associated with higher survival than type II tumours, so the proportion of these tumours may influence survival estimates for all ovarian cancers combined. The distribution of histological groups should be considered when comparing survival between countries and regions.
2017
144
2
405
413
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) / Matz, M.; Coleman, M. P.; Sant, M.; Chirlaque, M. D.; Visser, O.; Gore, M.; Allemani, C.; Bouzbid, S.; Hamdi-Cherif, M.; Zaidi, Z.; Bah, E.; Swaminathan, R.; Nortje, S. H.; C. Stefan, D.; El Mistiri, M. M.; Bayo, S.; Malle, B.; Manraj, S. S.; Sewpaul-Sungkur, R.; Fabowale, A.; Ogunbiyi, O. J.; Bradshaw, D.; Somdyala, N. I. M.; Abdel-Rahman, M.; Jaidane, L.; Mokni, M.; Kumcher, I.; Moreno, F.; Gonzalez, M. S.; Laura, E. A.; Espinola, S. B.; Calabrano, G. H.; Carballo Mazzoleni, G.; Giacomin, A.; Bella, F.; Castaing, M.; Sutera, A.; Gola, G.; Ferretti, S.; Serraino, D.; Zucchetto, A.; Lillini, R.; Vercelli, M.; Busco, S.; Pannozzo, F.; Vitarelli, S.; Ricci, P.; Pascucci, C.; Autelitano, M.; Cirilli, C.; Federico, M.; Fusco, M.; Vitale, M. F.; Usala, M.; Cusimano, R.; Mazzucco, W.; Michiara, M.; Sgargi, P.; Maule, M. M.; Sacerdote, C.; Tumino, R.; Di Felice, E.; Vicentini, M.; Falcini, F.; Cremone, L.; Budroni, M.; Cesaraccio, R.; Contrino, M. L.; Tisano, F.; Fanetti, A. C.; Maspero, S.; Candela, G.; Scuderi, T.; Gentilini, M. A.; Piffer, S.; Rosso, S.; Sacchetto, L.; Caldarella, A.; La Rosa, F.; Stracci, F.; Contiero, P.; Tagliabue, G.; Dei Tos, A. P.; Zorzi, M.; Zanetti, R.; Baili, P.; Berrino, F.; Gatta, G.; Capocaccia, R.; De Angelis, R.; Liepina, E.. - In: GYNECOLOGIC ONCOLOGY. - ISSN 0090-8258. - 144:2(2017), pp. 405-413. [10.1016/j.ygyno.2016.10.019]
Matz, M.; Coleman, M. P.; Sant, M.; Chirlaque, M. D.; Visser, O.; Gore, M.; Allemani, C.; Bouzbid, S.; Hamdi-Cherif, M.; Zaidi, Z.; Bah, E.; Swaminathan, R.; Nortje, S. H.; C. Stefan, D.; El Mistiri, M. M.; Bayo, S.; Malle, B.; Manraj, S. S.; Sewpaul-Sungkur, R.; Fabowale, A.; Ogunbiyi, O. J.; Bradshaw, D.; Somdyala, N. I. M.; Abdel-Rahman, M.; Jaidane, L.; Mokni, M.; Kumcher, I.; Moreno, F.; Gonzalez, M. S.; Laura, E. A.; Espinola, S. B.; Calabrano, G. H.; Carballo Mazzoleni, G.; Giacomin, A.; Bella, F.; Castaing, M.; Sutera, A.; Gola, G.; Ferretti, S.; Serraino, D.; Zucchetto, A.; Lillini, R.; Vercelli, M.; Busco, S.; Pannozzo, F.; Vitarelli, S.; Ricci, P.; Pascucci, C.; Autelitano, M.; Cirilli, C.; Federico, M.; Fusco, M.; Vitale, M. F.; Usala, M.; Cusimano, R.; Mazzucco, W.; Michiara, M.; Sgargi, P.; Maule, M. M.; Sacerdote, C.; Tumino, R.; Di Felice, E.; Vicentini, M.; Falcini, F.; Cremone, L.; Budroni, M.; Cesaraccio, R.; Contrino, M. L.; Tisano, F.; Fanetti, A. C.; Maspero, S.; Candela, G.; Scuderi, T.; Gentilini, M. A.; Piffer, S.; Rosso, S.; Sacchetto, L.; Caldarella, A.; La Rosa, F.; Stracci, F.; Contiero, P.; Tagliabue, G.; Dei Tos, A. P.; Zorzi, M.; Zanetti, R.; Baili, P.; Berrino, F.; Gatta, G.; Capocaccia, R.; De Angelis, R.; Liepina, E.
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0090825816314974-main.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 640.45 kB
Formato Adobe PDF
640.45 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1221478
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 96
  • ???jsp.display-item.citation.isi??? 92
social impact